In support of other recent studies,18 we note surprisingly low penetrance rates for GCK (77% of PTV carriers with T2D) and HNF1A (48%) for effects that are clinically considered to be highly/completely penetrant for monogenic forms of maturity-onset diabetes of the young (MODY; Table S1). Here, HNF1A is linked to type 2 diabetes mellitus.